|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Pei-Lin Lee | Alex.Yeh | Peter Lee | (02)8792-2699 | 7F, No.85, Xinhu 1st Rd.Taipei City 114, Taiwan(R.O.C.) | 2014/12/23 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | As the pioneer and technology leader in Digital Radiography, Swissray conducts their research activities and develops and manufactures their technologically advanced systems in Switzerland. The technology provides the highest quality medical radiographic images in seconds at a significantly lower cost and lower radiation dose than conventional or computed radiography because, among other factors, film, imaging plates, cassettes and chemical processing are not required. Swissray offers high quality, affordable solutions for direct digital radiography. All of Swissray's DR systems include the workflow optimized eXpert user interface with its unique fewest steps to exposure technology providing reduced patient preparation time and maximum productivity. |
Market Information ( 2024/04/23 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
57.125 | 46.45 | 44.50 | 46.45 | 1.65 | 58 | N/A | N/A | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/23) |
TPEx measures adopted (2024/04/23) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | Y | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |